1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
|
|
|
- CAS-Nr.
- 268545-13-7
- Englisch Name:
- 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
- Synonyma:
- ent-Moxifloxacin;d-Moxifloxacin;Moxifloxacin-11;Moxifloxacin isoMer;(4R,7R)-Moxifloxacin;Mosisasin Impurity G;ent-Moxifloxacin HCl;Moxifloxacin-R-isomer;Moxifloxacin impurity P;(4R,7R)-Moxifloxacin HCl
- CBNumber:
- CB62534736
- Summenformel:
- C21H24FN3O4
- Molgewicht:
- 401.43
- MOL-Datei:
- 268545-13-7.mol
|
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid Eigenschaften
- Schmelzpunkt:
- 226-228°C (dec.)
- Siedepunkt:
- 636.4±55.0 °C(Predicted)
- Dichte
- 1.408
- storage temp.
- -20°C Freezer
- L?slichkeit
- DMSO (Slightly), Methanol (Slightly), Water (Slightly)
- Aggregatzustand
- Solid
- pka
- 6.43±0.50(Predicted)
- Farbe
- Pale Yellow to Light Green
- InChIKey
- FABPRXSRWADJSP-BZNIZROVSA-N
- SMILES
- N1(C2CC2)C2=C(C=C(F)C(N3C[C@@]4([H])CCCN[C@@]4([H])C3)=C2OC)C(=O)C(C(O)=O)=C1
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
|
P264, P270, P301+P312, P330, P501 |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
|
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
|
P264, P280, P305+P351+P338,P337+P313P |
| H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
|
|
|
| Sicherheit |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Pale Yellow Solid
Verwenden
The (R,R)-Isomer of Moxifloxacin
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 94)Lieferanten
- 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-Quinolin-3-carboxylic acid
- 1-cyclopropyl-6-fluoro-7-((4aR,7aR)-
hexahydro-1H-pyrrolo[3,4-b]pyridin-
6(2H)-yl)-8-methoxy-4-oxo-1,4-
dihydroquinoline-3-carboxylic acid
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-
- Moxifloxacin impurity P
- (4R,7R)-Moxifloxacin Hydrochloride 2
- Moxifloxacin (R,R)-Isomer
- 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
- Moxifloxacin isoMer
- 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
- (4R,7R)-Moxifloxacin
- (4R,7R)-Moxifloxacin HCl
- Moxifloxacin EP Impurity G (ent-Moxifloxacin)
- 1-cyclopropyl-6-fluoro-8-methoxy-7-((4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- Moxifloxacin EP Impurity G?: Moxifloxacin Impurity G
- Moxifloxacin Impurity RR
- Mosisasin Impurity G
- 1-cyclopropyl-7-fluoro-8-methoxy-6-((4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- Moxifloxacin (R,R)-Isome
- Moxifloxacin-R-isomer
- Moxifloxacin impurity 12/Moxifloxacin EP Impurity G/Moxifloxacin-R-isomer/ent-Moxifloxacin/1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
- Moxifloxacin-11
- ent-Moxifloxacin Hydrochloride
- Moxifloxacin EP Impurity G
- ent-Moxifloxacin HCl
- 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxyli
- d-Moxifloxacin
- Moxifloxacin EP Impurity L
- Moxifloxacin Impurity RR(ent-Moxifloxacin Hydrochloride)
- Azilsartan medoxomil impurity276
- Moxifloxacin Impurity P(Moxifloxacin hydrochloride EP impurity G)
- 1-Cyclopropyl-6-fluoro-8-methoxy-7-((4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid (Moxifloxacin Impurity）
- Moxifloxacin Impurity 11 Monomer
- Moxifloxacin RR-isomer (ent-Moxifloxacin)
- Moxifloxacin Racemate HCl
- Moxifloxacin R,R-Isomer / Moxifloxacin EP
Impurity-G
- Moxifloxacin Impurity 11 Monomer (Moxifloxacin EP Impurity G)
- ent-Moxifloxacin
- 268545-13-7
- 268543-13-7
- Chiral Reagents
- Heterocycles
- Impurities
- Intermediates & Fine Chemicals
- Pharmaceuticals
